Industry Survey

Table of Contents

From the Intro

The SPL Working Group is conducting a survey of industry plans to implement business processes to support electronic submission of Drug Establishment Registration and Drug Product Listing in SPL format. Your participation in this survey would be greatly appreciated.

• This survey is applicable for Drug Establishment Registration and Drug Product Listing submissions made to CBER, CDER, and CVM.

• Your participation is anonymous. Your company name and your email address will only be used to collate and clarify answers if necessary and will not be made public.

• You do not need to be a member of the SPL Working Group to participate in the survey.

• The survey is conducted online. It will take approximately 10-15 minutes to complete.

• Blinded, collective survey results will be posted to the SPL Working Group Wiki site.

• FDA is NOT, in any way, involved in the preparation of this survey or the subsequent data collection effort. The results from this survey will not be provided to the FDA. FDA employees will not utilize the information collected from this survey in presentations or documentation related to the electronic drug registration and drug listing initiative or the Structured Product Labeling standard.